Endocannabinoid System Research: Cannabidiol’s Impact on Glucose Tolerance & Gut Health in Obese Adults
This pilot study examined cannabidiol gut microbiome obesity effects and found no significant improvement in glucose tolerance in sedentary overweight adults. While animal studies suggested metabolic benefits, these were not replicated here. Larger…
Investigating Cannabidiol’s Impact on Glucose Metabolism in Obesity
This study examines cannabidiol glucose metabolism obesity effects in sedentary overweight adults. Short-term low-dose CBD did not significantly improve glucose tolerance or alter gut microbiome composition. These findings suggest limited metabolic…
Evidence-Based Study on Cannabidiol and Glucose Tolerance
The cannabidiol glucose tolerance study examined the impact of low-dose CBD on glucose metabolism in sedentary adults with overweight or obesity. Results showed no significant improvements in glucose tolerance or gut microbiome changes. This study…
Endocannabinoid System Research: CBD Glucose Study Insights
Short-term low dose cannabidiol supplementation did not improve glucose tolerance in overweight adults. The study also found no significant changes in gut microbiota composition. These findings suggest limited metabolic benefits from short-term CBD use…
Investigating Cannabidiol’s Impact on Glucose Metabolism in Obesity
This pilot study investigates cannabidiol glucose metabolism obesity effects in overweight adults. Short-term low-dose CBD supplementation showed no significant improvements in glucose tolerance. The study also found no changes in gut microbiome…
Clinical Trial Findings on Short-Term Low-Dose Cannabidiol and Glucose Tolerance
This pilot study investigated short-term low-dose cannabidiol glucose tolerance effects in sedentary adults with overweight or obesity. The findings showed no measurable improvements in glucose tolerance or gut microbiome composition. These results…
Cannabidiol & Glucose Metabolism: Insights from Clinical Trials
This cannabidiol glucose metabolism study examined the effects of short-term low-dose CBD on glucose tolerance in sedentary adults with overweight or obesity. The clinical trial found no significant improvement in glucose metabolism or gut microbiome…
Cannabidiol & Glucose Tolerance: Clinical Research Findings
This pilot study examined short-term low-dose cannabidiol supplementation and its effects on glucose tolerance. The findings showed no improvement in glucose tolerance or gut microbiome changes. Short-term low-dose cannabidiol use alone is unlikely to…
Cannabidiol & Glucose Tolerance: Clinical Evidence Review
This review covers cannabidiol glucose tolerance clinical evidence from recent pilot studies. Short-term low-dose CBD supplementation did not improve glucose tolerance in overweight adults. The findings highlight the need for larger trials to clarify…
Research Digest: 20 Recent Studies – March 18, 2026
CED Clinical Relevance #85 Research Authority Peer-reviewed research curated for clinical relevance and evidence quality. Recent research digest. 20 of 20 most recent studies from our monitored feeds. CED Clinical Relevance #81 Research Authority…